您的瀏覽器不支援JavaScript功能,若網頁功能無法正常使用時,請開啟瀏覽器JavaScript狀態!
Some images has been designed using resources from
Unsplash
&
Pixabay
&
Pexels
&
Freepik
and some icons from
Flaticon
跳到主要內容
:::
回醫療體系歡迎頁
網站導覽
International
Facebook
小
中
大
其他分院
蘇澳分院
員山分院
桃園分院
新竹分院
玉里分院
鳳林分院
台東分院
關渡分院
臺北榮民總醫院遺傳諮詢中心
全球最佳醫院之一
搜尋
打開主選單
站內檢索
站內檢索
簡介
緣起
宗旨
組織架構
業務內容及服務項目
遺傳疾病諮詢服務門診
發展現況
未來發展
新生兒篩檢
歷年診斷人數統計
罕病照護(國健署計畫)
歷年活動
2024
2023
亞太區族群基因體學與精準醫學論壇
遺傳內分泌科亞洲遺傳代謝病國際會議,發表了五篇口頭報告和八篇海報,是各國參與者中最多。
兒科李麗虹護理師榮獲南丁格爾獎績優奉獻銅獎
10秒完成大數據搜尋!臺北榮總打造全基因定序分析系統,還導入AI來預測用藥風險
臺北榮民總醫院、道品股份有限公司、和鼎資産管理股份有限公司三方產學合作所開發的「精準醫療之基石-即時全基因分析系統」參加「財團法人生技醫療科技政策研究中心」所舉辦的第二十屆新創獎,榮獲「臨床新創獎」
2022
《博士開講》牛道明:全基因定序 有效防癌症與猝逝
龐貝氏症治療領先世界
衛生福利部季刊-第33期2022.06
2021
北榮「法布瑞氏症研究治療中心」 獲SNQ品質標章金質獎金獎
北榮牛道明 榮獲第31屆醫療奉獻獎
北榮牛道明獲醫療奉獻獎殊榮,記者會片段
照顧罕病兒不遺餘力 醫奉獎得主牛道明,頒獎典禮片段
罕病患者的希望 醫界奧斯卡得主無悔奉獻30年
2020
2020中華醫學會兒科醫學之新進展
好時節農莊自己做竹筒飯和Pizza
2019
108年歲末醫護衛教暨病友親子活動
威廉氏症候群病友會
牛道明主任 法布瑞氏症(Fabry) 國內外會議
香港龐貝氏症協會參訪
2018
牛道明主任 中華醫學會法布瑞氏症(Fabry)國內外會議
牛道明主任 107年法布瑞氏症(Fabry)豐碩的研究成果
牛道明主任 107年度「龐貝氏症醫療講座」
罕病新生兒血液濃如「草莓奶昔」 三酸甘油脂飆2萬險致命
2017
牛道明主任 受邀日本法布瑞氏症巡迴演講
牛道明主任 參與國內外醫療會議 紀錄分享
轉載自)TVBS 報導北榮牛道明主任法布瑞氏症(Fabry)-遺傳檢驗儀器捐贈儀式
2016
牛道明主任 法布瑞氏症(Fabry) 國內外會議 國際交流
轉載聯合報-臺北榮總牛道明主任-新生兒基因檢測 竟拯救了這名媽媽
2015
牛道明主任 法布瑞氏症(Fabry) 法布研討會
牛道明主任 台日法布瑞氏症(Fabry)研討會
2014
牛道明主任 至日本福岡分享台灣法布瑞氏症(Fabry)國際會議
牛道明主任 法布瑞氏症(Fabry)國際會議
國際交流 德國 Dr. Max J. Hilz 來訪並發表演講.
2013
牛道明主任 至西班牙法布瑞氏症(Fabry)國際會議
牛道明主任 至日本亞太溶酶體國際會議
牛道明主任團隊 至東京國際會議專題演講
牛道明主任 舉辦法布瑞氏症(Fabry)國際研討會
牛道明主任 法布瑞氏症(Fabry) 衛教講座活動
2012
牛道明主任 遺傳罕病法布瑞氏症 驗血早期發現
承接「台灣法布瑞氏症臨床試驗聯盟」計畫
門診看診流程
龐貝氏症初診流程
甲狀腺低下初診流程
法布瑞氏症初診流程
G6PD蠶豆症看診流程
生長曲線計算機
疾病衛教諮詢
生長激素刺激測試 Clonidine注意事項
水平凝視麻痺併漸進性脊柱側彎
性荷爾蒙檢查與性荷爾蒙藥劑住院常見問題須知
短鏈脂肪酸乙醯輔酶A去水解酶缺乏症
遺傳性高酪胺酸血症第二型
戊二酸血症第一型_發燒腹瀉急診處理
瓜氨酸血症第二型Citrullinemia type II
甲狀腺_用藥劑量衛教單
肝醣儲積症第1A型(Glycogen Storage Disease Type 1A)衛教資料
兒童青春期性早熟發育衛教單
法布瑞氏症 Fabry Disease
原發性肉毒鹼缺乏症
高胱胺酸尿症
腎上腺腦白質失養症Adrenoleukodystrophy
歌舞伎症候群 Kabuki Syndrome
龐貝氏症 (Pompe Disease)
體重過重與口服類固醇抑制測驗門診常見問題須知
羅素-西弗氏症Russell-Silver Syndrome
關於罕病物流中心
物流中心服務流程圖
罕病營養品
Calogen
Phlexy-Vits
PK AID 4
I-Valex-2
Glutarex-2
羅倫佐油
BCAD
Phenyl Free 1
Alfaré
GA1 Anamix
PFD
Essential Amino Acid
Phenyl free 2
HCU Anamix
GENERAID plus
IVA Anamix
Cyclinex-1
Cyclinex-2
Tyrex-1
Tyrex-2
Hominex-2
Pregestimil
I-Valex-1
Glutarex-1
Hominex-1
MMA/PA Anamix
單方胺基酸
罕病藥物
Arginine HCL Injection
BH4
Proglycem
Sodium Benzoate
Stimol
Buphenyl
Cystadane
Sucraid
Normosang
L-Carnitene
罕病相關食物
低蛋白真粒米
實驗室
意見箱
意見箱查詢處理狀況
管理介面(限院內)
下載
站內檢索
站內檢索
簡介
緣起
宗旨
組織架構
業務內容及服務項目
遺傳疾病諮詢服務門診
發展現況
未來發展
新生兒篩檢
歷年診斷人數統計
罕病照護(國健署計畫)
歷年活動
2024
2023
亞太區族群基因體學與精準醫學論壇
遺傳內分泌科亞洲遺傳代謝病國際會議,發表了五篇口頭報告和八篇海報,是各國參與者中最多。
兒科李麗虹護理師榮獲南丁格爾獎績優奉獻銅獎
10秒完成大數據搜尋!臺北榮總打造全基因定序分析系統,還導入AI來預測用藥風險
臺北榮民總醫院、道品股份有限公司、和鼎資産管理股份有限公司三方產學合作所開發的「精準醫療之基石-即時全基因分析系統」參加「財團法人生技醫療科技政策研究中心」所舉辦的第二十屆新創獎,榮獲「臨床新創獎」
2022
《博士開講》牛道明:全基因定序 有效防癌症與猝逝
龐貝氏症治療領先世界
衛生福利部季刊-第33期2022.06
2021
北榮「法布瑞氏症研究治療中心」 獲SNQ品質標章金質獎金獎
北榮牛道明 榮獲第31屆醫療奉獻獎
北榮牛道明獲醫療奉獻獎殊榮,記者會片段
照顧罕病兒不遺餘力 醫奉獎得主牛道明,頒獎典禮片段
罕病患者的希望 醫界奧斯卡得主無悔奉獻30年
2020
2020中華醫學會兒科醫學之新進展
好時節農莊自己做竹筒飯和Pizza
2019
108年歲末醫護衛教暨病友親子活動
威廉氏症候群病友會
牛道明主任 法布瑞氏症(Fabry) 國內外會議
香港龐貝氏症協會參訪
2018
牛道明主任 中華醫學會法布瑞氏症(Fabry)國內外會議
牛道明主任 107年法布瑞氏症(Fabry)豐碩的研究成果
牛道明主任 107年度「龐貝氏症醫療講座」
罕病新生兒血液濃如「草莓奶昔」 三酸甘油脂飆2萬險致命
2017
牛道明主任 受邀日本法布瑞氏症巡迴演講
牛道明主任 參與國內外醫療會議 紀錄分享
轉載自)TVBS 報導北榮牛道明主任法布瑞氏症(Fabry)-遺傳檢驗儀器捐贈儀式
2016
牛道明主任 法布瑞氏症(Fabry) 國內外會議 國際交流
轉載聯合報-臺北榮總牛道明主任-新生兒基因檢測 竟拯救了這名媽媽
2015
牛道明主任 法布瑞氏症(Fabry) 法布研討會
牛道明主任 台日法布瑞氏症(Fabry)研討會
2014
牛道明主任 至日本福岡分享台灣法布瑞氏症(Fabry)國際會議
牛道明主任 法布瑞氏症(Fabry)國際會議
國際交流 德國 Dr. Max J. Hilz 來訪並發表演講.
2013
牛道明主任 至西班牙法布瑞氏症(Fabry)國際會議
牛道明主任 至日本亞太溶酶體國際會議
牛道明主任團隊 至東京國際會議專題演講
牛道明主任 舉辦法布瑞氏症(Fabry)國際研討會
牛道明主任 法布瑞氏症(Fabry) 衛教講座活動
2012
牛道明主任 遺傳罕病法布瑞氏症 驗血早期發現
承接「台灣法布瑞氏症臨床試驗聯盟」計畫
門診看診流程
龐貝氏症初診流程
甲狀腺低下初診流程
法布瑞氏症初診流程
G6PD蠶豆症看診流程
生長曲線計算機
疾病衛教諮詢
生長激素刺激測試 Clonidine注意事項
水平凝視麻痺併漸進性脊柱側彎
性荷爾蒙檢查與性荷爾蒙藥劑住院常見問題須知
短鏈脂肪酸乙醯輔酶A去水解酶缺乏症
遺傳性高酪胺酸血症第二型
戊二酸血症第一型_發燒腹瀉急診處理
瓜氨酸血症第二型Citrullinemia type II
甲狀腺_用藥劑量衛教單
肝醣儲積症第1A型(Glycogen Storage Disease Type 1A)衛教資料
兒童青春期性早熟發育衛教單
法布瑞氏症 Fabry Disease
原發性肉毒鹼缺乏症
高胱胺酸尿症
腎上腺腦白質失養症Adrenoleukodystrophy
歌舞伎症候群 Kabuki Syndrome
龐貝氏症 (Pompe Disease)
體重過重與口服類固醇抑制測驗門診常見問題須知
羅素-西弗氏症Russell-Silver Syndrome
關於罕病物流中心
物流中心服務流程圖
罕病營養品
Calogen
Phlexy-Vits
PK AID 4
I-Valex-2
Glutarex-2
羅倫佐油
BCAD
Phenyl Free 1
Alfaré
GA1 Anamix
PFD
Essential Amino Acid
Phenyl free 2
HCU Anamix
GENERAID plus
IVA Anamix
Cyclinex-1
Cyclinex-2
Tyrex-1
Tyrex-2
Hominex-2
Pregestimil
I-Valex-1
Glutarex-1
Hominex-1
MMA/PA Anamix
單方胺基酸
罕病藥物
Arginine HCL Injection
BH4
Proglycem
Sodium Benzoate
Stimol
Buphenyl
Cystadane
Sucraid
Normosang
L-Carnitene
罕病相關食物
低蛋白真粒米
實驗室
意見箱
意見箱查詢處理狀況
管理介面(限院內)
下載
回醫療體系歡迎頁
網站導覽
English
International
BranchesHospital
SuaoHospital
YuanshanHospital
TaoyuanHospital
HsinchuHospital
YuLiHospital
FenglinHospital
TaitungHospital
GanDauHospital
Facebook
首頁
簡介
:::
楊純豪 (Shung-Haur Yang)
複診掛號
初診掛號
[簡介]
學歷
國立陽明大學 臨床醫學研究所 博士
國立陽明大學 醫學系 學士
經歷
現職:
- 迄今 國立陽明交通大學附設醫院 院長
- 迄今 臺北榮民總醫院 外科部直腸外科 特約主治醫師
- 迄今 國立陽明交通大學 醫學系外科學科 教授
- 迄今 台北榮民總醫院 外科部大腸直腸外科 特約醫師
經歷:
- 法國巴黎Institute Mutualite Montsouris
- 台北榮民總醫院 外科部實驗外科 主任
醫療專長
微創手術, 腹腔鏡大腸直腸手術, 達文西機械手臂輔助大腸直腸手術, 大腸直腸癌研究, 大腸直腸肛門疾病診斷治療, 大腸鏡檢查及息肉切除
證照
中華民國大腸直腸外科醫學會專科醫師
台灣消化系外科醫學會專科醫師
台灣外科醫學會專科醫師
中華民國大腸直腸外科醫學會達文西機械手臂輔助直腸手術證書
[著作]
Yang, Y. H., Lin, J. K., Chen, W. S., Lin, T. C., Yang, S. H., Jiang, J. K., Lan, Y. T., Lin, C. C., Yen, C. C., Tzeng, C. H., and Teng, H. W. (2014) Comparison of cetuximab to bevacizumab as the first-line bio-chemotherapy for patients with metastatic colorectal cancer: Superior progression-free survival is restricted to patients with measurable tumors and objective tumor response-a retrospective study, J Cancer Res Clin Oncol.
Yang, C. Y., Lu, R. H., Lin, C. H., Jen, C. H., Tung, C. Y., Yang, S. H., Lin, J. K., Jiang, J. K., and Lin, C. H. (2014) Single nucleotide polymorphisms associated with colorectal cancer susceptibility and loss of heterozygosity in a taiwanese population, PLoS One 9, e100060.
Wang, P. H., Tsui, K. H., and Yang, S. H. (2014) Incomplete flexible sigmoidoscopy insertion after cesarean section, J Chin Med Assoc 77, 115-116.
Wang, H. W., Yang, S. H., Huang, G. D., Lin, J. K., Chen, W. S., Jiang, J. K., Lan, Y. T., Lin, C. C., Hwang, W. L., Tzeng, C. H., Li, A. F., Yen, C. C., and Teng, H. W. (2014) Temsirolimus enhances the efficacy of cetuximab in colon cancer through a CIP2A-dependent mechanism, J Cancer Res Clin Oncol 140, 561-571.
Tseng, J. Y., Yang, C. Y., Liang, S. C., Liu, R. S., Yang, S. H., Lin, J. K., Chen, Y. M., Wu, Y. C., Jiang, J. K., and Lin, C. H. (2014) Interleukin-17A modulates circulating tumor cells in tumor draining vein of colorectal cancers and affects metastases, Clinical cancer research : an official journal of the American Association for Cancer Research 20, 2885-2897.
Lin, P. C., Lin, J. K., Lin, C. H., Lin, H. H., Yang, S. H., Jiang, J. K., Chen, W. S., Chou, C. C., Tsai, S. F., and Chang, S. C. (2014) Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution Array, Ann Surg Oncol.
Lin, J. K., Lin, P. C., Lin, C. H., Jiang, J. K., Yang, S. H., Liang, W. Y., Chen, W. S., and Chang, S. C. (2014) Clinical Relevance of Alterations in Quantity and Quality of Plasma DNA in Colorectal Cancer Patients: Based on the Mutation Spectra Detected in Primary Tumors, Ann Surg Oncol.
Lin, H. H., Lin, J. K., Jiang, J. K., Lin, C. C., Lan, Y. T., Yang, S. H., Wang, H. S., Chen, W. S., Lin, T. C., Liang, W. Y., and Chang, S. C. (2014) Clinicopathological analysis of colorectal carcinoid tumors and patient outcomes, World journal of surgical oncology 12, 366.
Lin, H. H., Chang, Y. Y., Lin, J. K., Jiang, J. K., Lin, C. C., Lan, Y. T., Yang, S. H., Wang, H. S., Chen, W. S., Lin, T. C., and Chang, S. C. (2014) The role of adjuvant chemotherapy in stage II colorectal cancer patients, Int J Colorectal Dis.
Lin, C. C., Lin, J. K., Lin, T. C., Chen, W. S., Yang, S. H., Wang, H. S., Lan, Y. T., Jiang, J. K., Yang, M. H., and Chang, S. C. (2014) The prognostic role of microsatellite instability, codon-specific KRAS, and BRAF mutations in colon cancer, J Surg Oncol.
Lan, Y. T., Yang, S. H., Lin, J. K., Lin, C. C., Wang, H. S., Chen, W. S., Lin, T. C., Jiang, J. K., and Chang, S. C. (2014) Genetic variations are associated with lymph node metastasis in colorectal cancer patients, J Surg Oncol 110, 307-312.
Lan, Y. T., Chang, S. C., Yang, S. H., Lin, C. C., Wang, H. S., Jiang, J. K., Chen, W. S., Lin, T. C., Chiou, S. H., and Lin, J. K. (2014) Comparison of clinicopathological characteristics and prognosis between early and late recurrence after curative surgery for colorectal cancer, Am J Surg 207, 922-930.
Hwang, W. L., Jiang, J. K., Yang, S. H., Huang, T. S., Lan, H. Y., Teng, H. W., Yang, C. Y., Tsai, Y. P., Lin, C. H., Wang, H. W., and Yang, M. H. (2014) MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells, Nature cell biology 16, 268-280.
Huang, C. S., Lin, J. K., Wang, L. W., Liang, W. Y., Lin, C. C., Lan, Y. T., Wang, H. S., Yang, S. H., Jiang, J. K., Chen, W. S., Lin, T. C., and Chang, S. C. (2014) Assessment of the value of carcinoembryonic antigen reduction ratio as a prognosis factor in rectal cancer, Am J Surg 208, 99-105.
Chen, H. M., Lin, J. K., Chen, W. S., Jiang, J. K., Yang, S. H., Lan, Y. T., Lin, C. C., and Teng, H. W. (2014) Reduced-intensity FOLFOXIRI in Treating Refractory Metastatic Colorectal Cancer: A Pilot Study, American journal of clinical oncology.
Chen, C. C., Lai, Y. L., Jiang, J. K., Chu, C. H., Huang, I. P., Chen, W. S., Cheng, A. Y., and Yang, S. H. (2014) The evolving practice of hybrid natural orifice transluminal endoscopic surgery (NOTES) for rectal cancer, Surg Endosc.
Chang, C. C., Lin, H. H., Lin, J. K., Lin, C. C., Lan, Y. T., Wang, H. S., Yang, S. H., Chen, W. S., Lin, T. C., Jiang, J. K., and Chang, S. C. (2014) FBXW7 mutation analysis and its correlation with clinicopathological features and prognosis in colorectal cancer patients, Int J Biol Markers, 0.
Yang, S. H., Jiang, J.K., Change, S.C., Huang, C.J., Lin, J,K, and Jen-Kou Lin. (2013 ) Clinical Significance of CA19-9 in the Follow-Up of Colorectal Cancer Patients with Elevated Preoperative Serum CA19-9, Hepato-Gastroenterology. 60.
Shao, Y. C., Chang, Y. Y., Lin, J. K., Lin, C. C., Wang, H. S., Yang, S. H., Jiang, J. K., Lan, Y. T., Lin, T. C., Li, A. F., Chen, W. S., and Chang, S. C. (2013) Neoadjuvant chemotherapy can improve outcome of colorectal cancer patients with unresectable metastasis, Int J Colorectal Dis.
Lu, Y. J., Lin, P. C., Lin, C. C., Wang, H. S., Yang, S. H., Jiang, J. K., Lan, Y. T., Lin, T. C., Liang, W. Y., Chen, W. S., Lin, J. K., and Chang, S. C. (2013) The Impact of the Lymph Node Ratio is Greater than Traditional Lymph Node Status in Stage III Colorectal Cancer Patients, World J Surg.
Ling-Wei Wang, T.-J. C., Chong-Yau Fu, Jen-Kou Lin, Shung-Haur Yang, . (2013) The Status of Sphincter-Preserving Surgery for Rectal Cancer in Taiwan: a 10-year Population-based Study, Hepatogastroenterology.
Lin, S. P., Lee, Y. T., Yang, S. H., Miller, S. A., Chiou, S. H., Hung, M. C., and Hung, S. C. (2013) Colon cancer stem cells resist antiangiogenesis therapy-induced apoptosis, Cancer Lett 328, 226-234.
Huang, C. J., Teng, H. W., Chien, C. C., Lin, J. K., and Yang, S. H. (2013) Prognostic Significance of C-Reactive Protein Polymorphism and KRAS/BRAF in Synchronous Liver Metastasis from Colorectal Cancer, PLoS One 8, e65117.
Yang, Y. H., Lin, J. K., Chen, W. S., Lin, T. C., Yang, S. H., Jiang, J. K., Chang, S. C., Lan, Y. T., Lin, C. C., Yen, C. C., Tzeng, C. H., Wang, W. S., Chiang, H. L., Teng, C. J., and Teng, H. W. (2012) Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot study, Support Care Cancer 20, 1491-1497.
Teng, H. W., Yang, S. H., Lin, J. K., Chen, W. S., Lin, T. C., Jiang, J. K., Yen, C. C., Li, A. F., Chen, P. C., Lan, Y. T., Lin, C. C., Hsu, Y. N., Wang, H. W., and Chen, K. F. (2012) CIP2A is a predictor of poor prognosis in colon cancer, J Gastrointest Surg 16, 1037-1047.
Teng, H. W., Huang, Y. C., Lin, J. K., Chen, W. S., Lin, T. C., Jiang, J. K., Yen, C. C., Li, A. F., Wang, H. W., Chang, S. C., Lan, Y. T., Lin, C. C., Wang, H. S., and Yang, S. H. (2012) BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy, J Surg Oncol 106, 123-129.
Lin, P. C., Lin, J. K., Lin, C. C., Wang, H. S., Yang, S. H., Jiang, J. K., Lan, Y. T., Lin, T. C., Li, A. F., Chen, W. S., and Chang, S. C. (2012) Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis, Int J Colorectal Dis 27, 1333-1338.
Lin, J. K., Lee, L. K., Chen, W. S., Lin, T. C., Jiang, J. K., Yang, S. H., Wang, H. S., Chang, S. C., Lan, Y. T., Lin, C. C., Yen, C. C., Liu, J. H., Tzeng, C. H., and Teng, H. W. (2012) Concurrent chemoradiotherapy followed by metastasectomy converts to survival benefit in stage IV rectum cancer, J Gastrointest Surg 16, 1888-1896.
Lin, C. C., Lai, Y. L., Lin, T. C., Chen, W. S., Jiang, J. K., Yang, S. H., Wang, H. S., Lan, Y. T., Liang, W. Y., Hsu, H. M., Lin, J. K., and Chang, S. C. (2012) Clinicopathologic features and prognostic analysis of MSI-high colon cancer, Int J Colorectal Dis 27, 277-286.
Lan, Y. T., Yang, S. H., Chang, S. C., Liang, W. Y., Li, A. F., Wang, H. S., Jiang, J. K., Chen, W. S., Lin, T. C., and Lin, J. K. (2012) Analysis of the seventh edition of American Joint Committee on colon cancer staging, Int J Colorectal Dis 27, 657-663.
Lan, Y. T., Lin, J. K., Lin, T. C., Chen, W. S., Jiang, J. K., Wang, H. S., Chang, S. C., and Yang, S. H. (2012) Prognostic significance of perioperative change of CEA level in colorectal patients when pre-operative level is normal, Hepatogastroenterology 59, 717-720.
Chien, C. C., Tu, T. C., Huang, C. J., Yang, S. H., and Lee, C. L. (2012) Lowly expressed ribosomal protein s19 in the feces of patients with colorectal cancer, ISRN Gastroenterol 2012, 394545.
Yang, S. H., Huang, C. J., Chang, S. C., and Lin, J. K. (2011) Association of C-reactive protein gene polymorphisms and colorectal cancer, Ann Surg Oncol 18, 1907-1915.
Tsai, K. S., Yang, S. H., Lei, Y. P., Tsai, C. C., Chen, H. W., Hsu, C. Y., Chen, L. L., Wang, H. W., Miller, S. A., Chiou, S. H., Hung, M. C., and Hung, S. C. (2011) Mesenchymal stem cells promote formation of colorectal tumors in mice, Gastroenterology 141, 1046-1056.
Liu, C. J., Lin, J. K., Chen, W. S., Lin, T. C., Yang, S. H., Jiang, J. K., Chang, S. C., Lan, Y. T., Yen, C. C., Tzeng, C. H., Wang, H. W., and Teng, H. W. (2011) The efficacy of chemotherapy in patients with high-grade metastatic colon cancer, Hepatogastroenterology 58, 1495-1501.
Lin, J. K., Yueh, T. C., Chang, S. C., Lin, C. C., Lan, Y. T., Wang, H. S., Yang, S. H., Jiang, J. K., Chen, W. S., and Lin, T. C. (2011) The influence of fecal diversion and anastomotic leakage on survival after resection of rectal cancer, J Gastrointest Surg 15, 2251-2261.
Lin, J. K., Lin, C. C., Yang, S. H., Wang, H. S., Jiang, J. K., Lan, Y. T., Lin, T. C., Li, A. F., Chen, W. S., and Chang, S. C. (2011) Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancer, Int J Colorectal Dis 26, 1135-1141.
Lin, J. K., Lin, A. J., Lin, C. C., Lan, Y. T., Yang, S. H., Li, A. F., and Chang, S. C. (2011) The status of EGFR-associated genes could predict the outcome and tumor response of chemo-refractory metastatic colorectal patients using cetuximab and chemotherapy, J Surg Oncol.
Lin, C. C., Lai, Y. L., Lin, T. C., Chen, W. S., Jiang, J. K., Yang, S. H., Wang, H. S., Lan, Y. T., Liang, W. Y., Hsu, H. M., Lin, J. K., and Chang, S. C. (2011) Clinicopathologic features and prognostic analysis of MSI-high colon cancer, Int J Colorectal Dis.
Lan, Y. T., Lin, J. K., Jiang, J. K., Chang, S. C., Liang, W. Y., and Yang, S. H. (2011) Significance of lymph node retrieval from the terminal ileum for patients with cecal and ascending colonic cancers, Ann Surg Oncol 18, 146-152.
Hwang, W. L., Yang, M. H., Tsai, M. L., Lan, H. Y., Su, S. H., Chang, S. C., Teng, H. W., Yang, S. H., Lan, Y. T., Chiou, S. H., and Wang, H. W. (2011) SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells, Gastroenterology 141, 279-291, 291 e271-275.
Huang, Y. C., Lin, J. K., Chen, W. S., Lin, T. C., Yang, S. H., Jiang, J. K., Chang, S. C., Lan, Y. T., Wang, H. S., Liu, C. Y., Yang, Y. W., and Teng, H. W. (2011) Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease, J Cancer Res Clin Oncol 137, 211-220.
Huang, C. J., Yang, S. H., Huang, S. M., Lin, C. M., Chien, C. C., Chen, Y. C., Lee, C. L., Wu, H. H., and Chang, C. C. (2011) A predicted protein, KIAA0247, is a cell cycle modulator in colorectal cancer cells under 5-FU treatment, J Transl Med 9, 82.
Hsu, Y. N., Liu, C. J., Lin, J. K., Chen, W. S., Lin, T. C., Yang, S. H., Jiang, J. K., Chang, S. C., Lan, Y. T., Lin, C. C., Yen, C. C., Liu, J. H., Tzeng, C. H., and Teng, H. W. (2011) Liver abscess after liver metastasectomy is a poor prognostic factor in patients with colorectal cancer, J Gastrointest Surg 15, 1798-1806.
Hsu, Y. N., Lin, J. K., Chen, W. S., Lin, T. C., Yang, S. H., Jiang, J. K., Chang, S. C., Yen, C. C., Tzeng, C. H., and Teng, H. W. (2011) A new classification scheme for recurrent or metastatic colon cancer after liver metastasectomy, J Chin Med Assoc 74, 493-499.
Chou, C. L., Chang, S. C., Lin, T. C., Chen, W. S., Jiang, J. K., Wang, H. S., Yang, S. H., Liang, W. Y., and Lin, J. K. (2011) Differences in clinicopathological characteristics of colorectal cancer between younger and elderly patients: an analysis of 322 patients from a single institution, Am J Surg 202, 574-582.
Yang Shung-Haur, C.-J. H., Chia-Long Lee, Chen-Chiung Liu, Chih-Cheng Chie, Shu-Hung Chen. (2010) Fecal RNA Detection of Cytokeratin 19 and Ribosomal Protein L19 for Colorectal Cancer, Hepato-Gastroenterology. 57, 710-715.
Yang, R. N., Yang, S. H., Chang, C. C., Chien, C. C., Pan, S., and Huang, C. J. (2010) Upregulation of fecal cytokeratin 19 is associated with prognosis in older colorectal cancer patients, Genet Test Mol Biomarkers 14, 703-708.
Lin, J. K., Shen, M. Y., Lin, T. C., Lan, Y. T., Wang, H. S., Yang, S. H., Li, A. F., and Chang, S. C. (2010) Distribution of a single nucleotide polymorphism of insulin-like growth factor-1 in colorectal cancer patients and its association with mucinous adenocarcinoma, Int J Biol Markers 25, 195-199.
Lan, Y. T., Yang, S. H., Li, A. F., and Lin, J. K. (2010) Conflicting finding on intramucosal colon cancers based on national survival outcomes data, J Clin Oncol 28, e469; author reply e470.
Kao, P. S., Chang, S. C., Wang, L. W., Lee, R. C., Liang, W. Y., Lin, T. C., Chen, W. S., Jiang, J. K., Yang, S. H., Wang, H. S., and Lin, J. K. (2010) The impact of preoperative chemoradiotherapy on advanced low rectal cancer, J Surg Oncol 102, 771-777.
Huang, Y. C., Lin, J. K., Chen, W. S., Lin, T. C., Yang, S. H., Jiang, J. K., Chang, S. C., Lan, Y. T., Wang, H. S., Liu, C. Y., Yang, Y. W., and Teng, H. W. (2010) Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease, J Cancer Res Clin Oncol.
Chang, S. C., Lin, P. C., Yang, S. H., Wang, H. S., Liang, W. Y., and Lin, J. K. (2010) Taiwan hospital-based detection of Lynch syndrome distinguishes 2 types of microsatellite instabilities in colorectal cancers, Surgery 147, 720-728.
Lin, C. C., Lin, J. K., Chang, S. C., Wang, H. S., Yang, S. H., Jiang, J. K., Chen, W. S., and Lin, T. C. (2009) Is adjuvant chemotherapy beneficial to high risk stage II colon cancer? Analysis in a single institute, International Journal of Colorectal Disease 24, 665-676.
Lai, R. H., Wang, M. J., Yang, S. H., and Chen, J. Y. (2009) Genomic organization and functional characterization of the promoter for the human suppressor of cytokine signaling 6 gene, Gene 448, 64-73.
Chang, S. C., Lin, P. C., Yang, S. H., Wang, H. S., Liang, W. Y., and Lin, J. K. (2009) Mitochondrial D-loop mutation is a common event in colorectal cancers with p53 mutations, International Journal of Colorectal Disease 24, 623-628.
Chang, S. C., Lin, P. C., Yang, S. H., Wang, H. S., Li, A. F., and Lin, J. K. (2009) SDF-1alpha G801A polymorphism predicts lymph node metastasis in stage T3 colorectal cancer, Ann Surg Oncol 16, 2323-2330.
Chang, C. C., Yang, S. H., Chien, C. C., Chen, S. H., Pan, S., Lee, C. L., Lin, C. M., Sun, H. L., Huang, C. C., Wu, Y. Y., Yang, R. N., and Huang, C. J. (2009) Clinical meaning of age-related expression of fecal cytokeratin 19 in colorectal malignancy, BMC Cancer 9, 376.